ID   AK1BF_HUMAN             Reviewed;         316 AA.
AC   C9JRZ8; C9J3V2;
DT   13-JUL-2010, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-2015, sequence version 2.
DT   12-APR-2017, entry version 65.
DE   RecName: Full=Aldo-keto reductase family 1 member B15 {ECO:0000305};
DE            EC=1.1.1.- {ECO:0000269|PubMed:25577493};
DE   AltName: Full=Estradiol 17-beta-dehydrogenase AKR1B15 {ECO:0000305};
DE            EC=1.1.1.62 {ECO:0000269|PubMed:25577493};
GN   Name=AKR1B15 {ECO:0000312|HGNC:HGNC:37281};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   TISSUE=Eye, and Testis;
RX   PubMed=21276782; DOI=10.1016/j.cbi.2011.01.020;
RA   Salabei J.K., Li X.P., Petrash J.M., Bhatnagar A., Barski O.A.;
RT   "Functional expression of novel human and murine AKR1B genes.";
RL   Chem. Biol. Interact. 191:177-184(2011).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   FUNCTION (ISOFORMS 1 AND 2), CATALYTIC ACTIVITY (ISOFORM 1),
RP   BIOPHYSICOCHEMICAL PROPERTIES (ISOFORM 1), SUBCELLULAR LOCATION
RP   (ISOFORMS 1 AND 2), ALTERNATIVE SPLICING (ISOFORMS 1 AND 2), AND
RP   TISSUE SPECIFICITY.
RX   PubMed=25577493; DOI=10.1074/jbc.M114.610121;
RA   Weber S., Salabei J.K., Moller G., Kremmer E., Bhatnagar A.,
RA   Adamski J., Barski O.A.;
RT   "Aldo-keto reductase 1B15 (AKR1B15): a mitochondrial human aldo-keto
RT   reductase with activity towards steroids and 3-keto-acyl-coa
RT   conjugates.";
RL   J. Biol. Chem. 290:6531-6545(2015).
CC   -!- FUNCTION: Isoform 1: Mainly acts as a reductive enzyme that
CC       catalyzes the reduction of androgens and estrogens with high
CC       positional selectivity (shows 17-beta-hydroxysteroid dehydrogenase
CC       activity) as well as 3-keto-acyl-CoAs. Has a strong selectivity
CC       towards NADP(H) (PubMed:25577493). {ECO:0000269|PubMed:21276782,
CC       ECO:0000269|PubMed:25577493}.
CC   -!- FUNCTION: Isoform 2: No oxidoreductase activity observed with the
CC       tested substrates. {ECO:0000269|PubMed:25577493}.
CC   -!- CATALYTIC ACTIVITY: 17-beta-estradiol + NAD(P)(+) = estrone +
CC       NAD(P)H. {ECO:0000269|PubMed:25577493}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.8 uM for androsterone (tested with isoform 1 in the
CC         reductive reaction) {ECO:0000269|PubMed:25577493};
CC         KM=1.9 uM for delta-4-androstenedione (tested with isoform 1 in
CC         the reductive reaction) {ECO:0000269|PubMed:25577493};
CC         KM=2.5 uM for estrone (tested with isoform 1 in the reductive
CC         reaction) {ECO:0000269|PubMed:25577493};
CC         KM=63.4 uM for acetoacetyl-CoA (tested with isoform 1 in the
CC         reductive reaction) {ECO:0000269|PubMed:25577493};
CC         KM=19.2 uM for 3-alpha,17-beta-androstandiol (tested with
CC         isoform 1 in the oxidative reaction)
CC         {ECO:0000269|PubMed:25577493};
CC         KM=7.1 uM for testosterone (tested with isoform 1 in the
CC         oxidative reaction) {ECO:0000269|PubMed:25577493};
CC         KM=9.1 uM for 17-beta-estradiol (tested with isoform 1 in the
CC         oxidative reaction) {ECO:0000269|PubMed:25577493};
CC         Note=kcat is 1.7 min(-1) using isoform 1 for the reduction of
CC         androsterone. kcat is 1.1 min(-1) using isoform 1 for the
CC         reduction of delta-4-androstenedione. kcat is 1.0 min(-1) using
CC         isoform 1 for the reduction of estrone. kcat is 0.5 min(-1)
CC         using isoform 1 for the reduction of acetoacetyl-CoA. kcat is
CC         3.0 min(-1) using isoform 1 for the oxidation of 3-alpha,17-
CC         beta-androstandiol. kcat is 0.6 min(-1) using isoform 1 for the
CC         oxidation of testosterone. kcat is 0.5 min(-1) using isoform 1
CC         for the oxidation of 17-beta-estradiol.
CC         {ECO:0000269|PubMed:25577493};
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Mitochondrion
CC       {ECO:0000269|PubMed:25577493}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:25577493}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=AKR1B15.1 {ECO:0000303|PubMed:25577493};
CC         IsoId=C9JRZ8-1; Sequence=Displayed;
CC       Name=2; Synonyms=AKR1B15.2 {ECO:0000303|PubMed:25577493};
CC         IsoId=C9JRZ8-2; Sequence=VSP_041606;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed at highest levels
CC       in steroid-sensitive tissues, such as placenta, testis and adipose
CC       tissue. {ECO:0000269|PubMed:25577493}.
CC   -!- SIMILARITY: Belongs to the aldo/keto reductase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC078847; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471070; EAW83819.1; -; Genomic_DNA.
DR   CCDS; CCDS47715.2; -. [C9JRZ8-2]
DR   RefSeq; NP_001074007.2; NM_001080538.2. [C9JRZ8-2]
DR   RefSeq; XP_011514543.2; XM_011516241.2. [C9JRZ8-1]
DR   RefSeq; XP_016867713.1; XM_017012224.1. [C9JRZ8-2]
DR   UniGene; Hs.729418; -.
DR   ProteinModelPortal; C9JRZ8; -.
DR   SMR; C9JRZ8; -.
DR   BioGrid; 137330; 11.
DR   STRING; 9606.ENSP00000389289; -.
DR   SwissLipids; SLP:000001307; -. [C9JRZ8-1]
DR   iPTMnet; C9JRZ8; -.
DR   PhosphoSitePlus; C9JRZ8; -.
DR   BioMuta; AKR1B15; -.
DR   EPD; C9JRZ8; -.
DR   MaxQB; C9JRZ8; -.
DR   PaxDb; C9JRZ8; -.
DR   PRIDE; C9JRZ8; -.
DR   Ensembl; ENST00000423958; ENSP00000397009; ENSG00000227471. [C9JRZ8-2]
DR   Ensembl; ENST00000457545; ENSP00000389289; ENSG00000227471. [C9JRZ8-2]
DR   GeneID; 441282; -.
DR   KEGG; hsa:441282; -.
DR   UCSC; uc011kpr.3; human. [C9JRZ8-1]
DR   CTD; 441282; -.
DR   GeneCards; AKR1B15; -.
DR   HGNC; HGNC:37281; AKR1B15.
DR   HPA; HPA020280; -.
DR   HPA; HPA073633; -.
DR   MIM; 616336; gene.
DR   neXtProt; NX_C9JRZ8; -.
DR   OpenTargets; ENSG00000227471; -.
DR   PharmGKB; PA165617622; -.
DR   eggNOG; KOG1577; Eukaryota.
DR   eggNOG; COG0656; LUCA.
DR   GeneTree; ENSGT00760000119041; -.
DR   HOGENOM; HOG000250272; -.
DR   InParanoid; C9JRZ8; -.
DR   OMA; QHEVGEA; -.
DR   OrthoDB; EOG091G0D69; -.
DR   TreeFam; TF106492; -.
DR   Reactome; R-HSA-193144; Estrogen biosynthesis.
DR   GenomeRNAi; 441282; -.
DR   PRO; PR:C9JRZ8; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000227471; -.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0004303; F:estradiol 17-beta-dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0016616; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; IDA:UniProtKB.
DR   GO; GO:0006703; P:estrogen biosynthetic process; TAS:Reactome.
DR   CDD; cd06660; Aldo_ket_red; 1.
DR   Gene3D; 3.20.20.100; -; 1.
DR   InterPro; IPR018170; Aldo/ket_reductase_CS.
DR   InterPro; IPR020471; Aldo/keto_reductase.
DR   InterPro; IPR023210; NADP_OxRdtase_dom.
DR   PANTHER; PTHR11732; PTHR11732; 1.
DR   Pfam; PF00248; Aldo_ket_red; 1.
DR   PIRSF; PIRSF000097; AKR; 1.
DR   PRINTS; PR00069; ALDKETRDTASE.
DR   SUPFAM; SSF51430; SSF51430; 1.
DR   PROSITE; PS00062; ALDOKETO_REDUCTASE_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome; Cytoplasm;
KW   Mitochondrion; NADP; Oxidoreductase; Reference proteome.
FT   CHAIN         1    316       Aldo-keto reductase family 1 member B15.
FT                                /FTId=PRO_0000395341.
FT   NP_BIND      20     22       NADP. {ECO:0000250|UniProtKB:O60218}.
FT   NP_BIND     160    161       NADP. {ECO:0000250|UniProtKB:O60218}.
FT   NP_BIND     210    217       NADP. {ECO:0000250|UniProtKB:O60218}.
FT   NP_BIND     261    273       NADP. {ECO:0000250|UniProtKB:O60218}.
FT   ACT_SITE     49     49       Proton donor.
FT                                {ECO:0000250|UniProtKB:O60218}.
FT   BINDING      44     44       NADP. {ECO:0000250|UniProtKB:O60218}.
FT   BINDING     111    111       Substrate.
FT                                {ECO:0000250|UniProtKB:O60218}.
FT   BINDING     184    184       NADP. {ECO:0000250|UniProtKB:O60218}.
FT   SITE         78     78       Lowers pKa of active site Tyr.
FT                                {ECO:0000250|UniProtKB:P14550}.
FT   MOD_RES     125    125       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:O60218}.
FT   MOD_RES     263    263       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:O60218}.
FT   VAR_SEQ       1     22       MATFVELSTKAKMPIVGLGTWR -> MVLQMEPQVNSTNNF
FT                                HQGPLDQPVGPLTGLKSSLLKDTTSAGPLLRPYPA (in
FT                                isoform 2). {ECO:0000269|PubMed:21276782,
FT                                ECO:0000269|PubMed:25577493}.
FT                                /FTId=VSP_041606.
SQ   SEQUENCE   316 AA;  36537 MW;  5FB6CBFA7190C740 CRC64;
     MATFVELSTK AKMPIVGLGT WRSLLGKVKE AVKVAIDAEY RHIDCAYFYE NQHEVGEAIQ
     EKIQEKAVMR EDLFIVSKVW PTFFERPLVR KAFEKTLKDL KLSYLDVYLI HWPQGFKTGD
     DFFPKDDKGN MISGKGTFLD AWEAMEELVD EGLVKALGVS NFNHFQIERL LNKPGLKYKP
     VTNQVECHPY LTQEKLIQYC HSKGITVTAY SPLGSPDRPW AKPEDPSLLE DPKIKEIAAK
     HKKTTAQVLI RFHIQRNVTV IPKSMTPAHI VENIQVFDFK LSDEEMATIL SFNRNWRAFD
     FKEFSHLEDF PFDAEY
//
